Craig-Hallum Upgrades Rezolute to Buy, Raises Price Target to $7

9/29/2026
Impact: 70
Healthcare

Craig-Hallum analyst Albert Lowe has upgraded Rezolute (NASDAQ: RZLT) from a Hold to a Buy rating. The price target for the stock has been raised from $4 to $7.

AI summary, not financial advice

Share: